China Medicine Corporation
CHME · OTC
9/30/2010 | 6/30/2010 | 3/31/2010 | 12/31/2009 | |
|---|---|---|---|---|
| Revenue | $17,550 | $17,190 | $10,572 | $20,442 |
| % Growth | 2.1% | 62.6% | -48.3% | – |
| Cost of Goods Sold | $11,746 | $11,083 | $7,325 | $13,599 |
| Gross Profit | $5,804 | $6,107 | $3,247 | $6,842 |
| % Margin | 33.1% | 35.5% | 30.7% | 33.5% |
| R&D Expenses | $1,252 | $345 | $364 | $770 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $2,066 | $1,974 | $1,637 | $1,889 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $3,318 | $2,319 | $2,001 | $2,659 |
| Operating Income | $2,486 | $3,789 | $1,246 | $4,183 |
| % Margin | 14.2% | 22% | 11.8% | 20.5% |
| Other Income/Exp. Net | $596 | $1,326 | $989 | -$5,132 |
| Pre-Tax Income | $3,082 | $5,114 | $2,235 | -$949 |
| Tax Expense | $941 | $1,089 | $513 | $1,218 |
| Net Income | $2,223 | $4,103 | $1,798 | -$2,095 |
| % Margin | 12.7% | 23.9% | 17% | -10.2% |
| EPS | 0.1 | 0.19 | -0.23 | -0.14 |
| % Growth | -47.4% | 182.6% | -64.3% | – |
| EPS Diluted | 0.06 | 0.1 | -0.23 | -0.14 |
| Weighted Avg Shares Out | 21,886 | 21,886 | 18,897 | 15,267 |
| Weighted Avg Shares Out Dil | 39,592 | 39,993 | 18,897 | 15,411 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $424 | $467 | $462 | $349 |
| EBITDA | $2,910 | $4,256 | $1,709 | $4,532 |
| % Margin | 16.6% | 24.8% | 16.2% | 22.2% |